Transport of fragile X mental retardation protein via granules in neurites of PC12 cells by Diego Otero, Y. (Yolanda) de et al.
MOLECULAR AND CELLULAR BIOLOGY, Dec. 2002, p. 8332–8341 Vol. 22, No. 23
0270-7306/02/$04.000 DOI: 10.1128/MCB.22.23.8332–8341.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
Transport of Fragile X Mental Retardation Protein via Granules in
Neurites of PC12 Cells
Yolanda De Diego Otero,1† Lies-Anne Severijnen,1 Gert van Cappellen,2 Marie¨tte Schrier,1
Ben Oostra,1 and Rob Willemsen1*
CBG Department of Clinical Genetics1 and Department of Endocrinology and Reproduction,2 Erasmus University,
Rotterdam, The Netherlands
Received 7 June 2002/Returned for modification 14 August 2002/Accepted 5 September 2002
Lack of fragile X mental retardation protein (FMRP) causes fragile X syndrome, a common form of
inherited mental retardation. FMRP is an RNA binding protein thought to be involved in translation efficiency
and/or trafficking of certain mRNAs. Recently, a subset of mRNAs to which FMRP binds with high affinity has
been identified. These FMRP-associated mRNAs contain an intramolecular G-quartet structure. In neurons,
dendritic mRNAs are involved in local synthesis of proteins in response to synaptic activity, and this represents
a mechanism for synaptic plasticity. To determine the role of FMRP in dendritic mRNA transport, we have
generated a stably FMR1-enhanced green fluorescent protein (EGFP)-transfected PC12 cell line with an
inducible expression system (Tet-On) for regulated expression of the FMRP-GFP fusion protein. After doxy-
cycline induction, FMRP-GFP was localized in granules in the neurites of PC12 cells. By using time-lapse
microscopy, the trafficking of FMRP-GFP granules into the neurites of living PC12 cells was demonstrated.
Motile FMRP-GFP granules displayed two types of movements: oscillatory (bidirectional) and unidirectional
anterograde. The average velocity of the granules was 0.19 m/s with a maximum speed of 0.71 m/s. In
addition, we showed that the movement of FMRP-GFP labeled granules into the neurites was microtubule
dependent. Colocalization studies further showed that the FMRP-GFP labeled granules also contained RNA,
ribosomal subunits, kinesin heavy chain, and FXR1P molecules. This report is the first example of trafficking
of RNA-containing granules with FMRP as a core constituent in living PC12 cells.
Fragile X syndrome is one of the most prevalent causes of
inheritable mental retardation, with a frequency of 1:4,000
males (26). This X-linked disorder is caused by the absence of
the fragile X mental retardation protein (FMRP). FMRP ex-
pression is widespread with abundant expression in neurons
and trafficking to dendrites in particular and with testicular
expression in spermatogonia (3, 14, 15, 38, 43). The association
of FMRP with ribosomes is mRNA dependent via ribonucle-
oprotein (RNP) particles, which contain several other proteins
including the fragile X (structurally)-related proteins FXR1P
and FXR2P (10). Microscopic analysis of autopsy material
from fragile X patients and brain pathology studies of Fmr1-
knockout mice have indicated dendritic spines abnormal in size
and shape, and a function in maturation of spines has been
attributed to FMRP (11, 19).
FMRP contains RNA-binding sequence motifs, including
two KH domains and an RGG box (2, 34). The precise phys-
iological function of FMRP is still not defined; however, a role
in transport and/or translational efficiency of mRNAs has been
suggested elsewhere (27, 28). Recently, there has been identi-
fied a subset of mRNAs containing a G quartet that is a
potential target for FMRP, including those for important neu-
ronal proteins like microtubule-associated protein MAP1B
and semaphorin (6, 13). It has been suggested that the absence
of FMRP in neurons results in misregulation or mistrafficking
of a subset of mRNAs and that this is the basis of the mental
retardation in fragile X syndrome.
Interestingly, recent evidence shows that mRNA transport-
translation in dendrites plays an important role in neuronal
processes, including synaptic plasticity, which is essential for
memory storage and learning processes (21). Most dendritic
polyribosomes are located within or at the base of spines, and
it has been hypothesized that local protein synthesis at the
synapse may be an important aspect of proper synaptogenesis
(35). The presence of the protein machinery, postsynaptically,
allows neurons to rapidly respond to signals at particular syn-
apses through local translation of (specific) mRNAs. For this
purpose, efficient transport of specific mRNAs, via mRNP
particles, has to be established to this cellular location followed
by efficient translation of mRNAs in the vicinity of the synapse.
The dynamics of the transport of mRNP particles in neurons
have been studied by different experimental approaches, and a
supramolecular complex containing mRNAs, translational fac-
tors, and ribosomal subunits has been identified (4). The mi-
gration of mRNP particles over long distances within the den-
drites toward the growth cone is established by movement
along microtubules via a mechanism involving cytoplasmic ki-
nesin, a plus-end-directed microtubule motor protein (8, 24,
25, 39). On the other hand the migration of mRNP particles
over shorter distances may require microfilaments, such as
actin filaments for the transport of -actin mRNAs in fibro-
blasts (37).
Since FMRP in neurons may be involved in local dendritic
protein synthesis, related to synaptic function and plasticity, it
* Corresponding author. Mailing address: Department of Clinical
Genetics, Erasmus University, P.O. Box 1738, 3000 DR Rotterdam,
The Netherlands. Phone: (31) 10-4087152. Fax: (31) 10-4089489. E-
mail: willemsen@ch1.fgg.eur.nl.
† Present address: Carlos Haya Hospital Research Laboratory,
Malaga, Spain.
8332
is important to identify the subset of target mRNAs and un-
derstand how FMRP functions in their delivery into the den-
drites. In the present study we visualized FMRP in vivo in a
PC12 cell line stably transfected with a human FMR1-en-
hanced green fluorescent protein fusion (FMR1-EGFP) gene
as a first step to study the role of FMRP-GFP-containing
granules in dendritic mRNA transport and translation.
MATERIALS AND METHODS
Cell culture, expression vectors, and transfection. Rat pheochromocytoma
cells (PC12) were used with a Tet-On gene expression system because this cell
system permits tightly regulated expression of the FMR1 gene in response to
doxycycline (DOX; doxycycline hydrochloride; Sigma D9891; 1 g/ml). PC12
Tet-On cells were obtained from Clontech and grown as specified by the man-
ufacturer. Briefly, cells were cultured in Dulbecco modified Eagle medium
(DMEM) supplemented with 10% horse serum, 5% fetal bovine serum, 125 g
of hygromycin/ml, 100 g of penicillin-streptomycin/ml, and 100 g of G418/ml
in a 10% CO2 incubator at 37°C. PC12 cells were differentiated into a neuronal
phenotype on collagen-coated coverslips in medium supplemented with 100 ng of
nerve growth factor (NGF-7S; Sigma)/ml for 72 h (DMEM, G418, hygromycin,
0.75% horse serum, 0.25% fetal bovine serum).
The cloning of the expression plasmids for the human FMRP-GFP fusion
protein (pFMRP-EGFP) was described by Castren et al. (9). The pFMRP-EGFP
construct was cloned into the pTRE response plasmid (Clontech) to generate a
double stable transfected Tet-On cell line, by the Lipofectamine procedure (30
l of Lipofectamine from GibcoBRL and 20 g of plasmid DNA). The pHyg
resistance vector was used in the cotransfection as a selection marker. Trans-
fected cells were cultured in medium containing hygromycin (0.125 mg/ml; Gib-
coBRL) and DOX (1 g/ml), and subsequently individual double stable cell
colonies were tested and further selected for the presence of the FMRP-GFP
fusion protein by fluorescence microscopy. Several cell lines (n  11) were
selected on the basis of both the presence of FMRP-GFP fusion protein after
DOX treatment and the absence of the FMRP-GFP fusion protein without DOX
treatment (leakage) and further investigated by Western blotting and immuno-
cytochemistry.
For primary cultures of mouse (wild-type [wt]) hippocampal neurons, hip-
pocampi were dissected from E19 old mouse brains and prepared and cultured
as described before (38).
Antibodies and reagents. The following antibodies were used: monoclonal
antibody to human FMRP (clone 1C3; 1:800) (14), monoclonal anti-GFP anti-
body (1:2,000; Roche USA no. 1814460), monoclonal anti-FXR1P (3FX; 1:500)
(20), monoclonal anti-tyrosine-tubulin (1:100; clone TUB-1A2; Sigma), human
anti-ribosomal P antigen (1:100; P0; Immunovision), and monoclonal anti-kine-
sin heavy chains (1:100; clone IBII; Sigma). Texas red-labeled phallotoxins were
used to visualize F-actin (1:50; T-7471; Molecular Probes). As secondary anti-
bodies we used swine anti-rabbit immunoglobulin (Ig) conjugated with horse-
radish peroxidase (HRP; 1:100; P0217; DAKO), goat anti-human Ig conjugated
with tetramethyl rhodamine isocyanate (TRITC; 1:100; T-5903; Sigma), and
rabbit anti-mouse Ig conjugated with HRP (1:100; P0260; DAKO). We used 1
M ethidium bromide (EtBr; Fluka) in phosphate-buffered saline (PBS) to
fluorescently label total cellular RNA according to the method of Tang et al.
(39). Under these experimental conditions, the EtBr signal is sensitive for RNase
treatment but not for DNase treatment, indicating specificity for RNA localiza-
tion. Unfortunately, the fluorescent dye SYTO14 could not be used to label
cellular RNA because the emitted light of SYTO14 overlapped with GFP fluo-
rescence.
All drug treatments were carried out in DMEM (complete) at 37°C. To block
mRNA translation, cells were pretreated with DOX for 30 min followed by
treatment with cycloheximide (30 g/ml; Sigma) for another 2 h. This concen-
tration of cycloheximide results in a total block of protein synthesis, which was
demonstrated by treatment of PC12/FMR7 cells with DOX and cycloheximide
simultaneously for 6 h (data not shown). To disrupt microfilaments, cells were
pretreated for 30 min with DOX followed by treatment with both DOX and
cytochalasin D (5 g/ml; Sigma) for another 2 h before fixation. Depolymeriza-
tion of microtubules was accomplished by pretreatment of cells with DOX for 30
min followed by treatment with both DOX and nocodazole (10 M; Sigma) for
another 2 h before fixation.
Western blotting and immunocytochemistry. PC12 Tet-On cells and 11 se-
lected PC12 Tet-On cell lines stably transfected with pFMRP-EGFP (designated
PC12/FMR1 to PC12/FMR11) were grown with and without the presence of
DOX. Cells were harvested after 24 h, and lysates from the different cell lines
were run on a 10% gel and blotted onto nitrocellulose. Immunodetection of the
FMRP-GFP fusion protein was performed with monospecific antibodies against
GFP followed by an incubation with secondary antibodies coupled to peroxidase,
allowing detection by the chemiluminescence method (ECL kit; Amersham).
Cellular FMRP-GFP distribution was studied by both direct immunofluores-
cence and the indirect immunoperoxidase technique. Cells were cultured on
collagen-coated coverslips and treated with NGF for 72 h followed by treatment
with both DOX and NGF for times varying from 1 to 72 h. For direct visualiza-
tion of GFP by immunofluorescence, cells were fixed with 95% ethanol for 30
min at room temperature (RT). Wash steps were carried out with 0.1 M PBS, and
coverslips were mounted with Vectashield mounting medium. In the colocaliza-
tion studies, cells were incubated with primary antibodies against different mark-
ers (see above for antibodies) for 1 h at RT followed by a 45-min incubation with
TRITC-conjugated secondary antibodies. Cells were examined with a Leitz flu-
orescence microscope with a 63 objective, standard fluorescein isothiocyanate
and TRITC filters, a 100-W HBO mercury light source, and a Sony DXC-95OP
3CCD color video camera.
The endogenous FMRP expression in both PC12 cells and primary mouse (wt)
hippocampal neurons was studied by an indirect immunofluorescence technique
with monoclonal antibodies to FMRP (14). For indirect immunoperoxidase
labeling, cells were fixed in 3% paraformaldehyde for 10 min at RT, followed by
a permeabilization step in 100% methanol for 20 min at RT. Endogenous
peroxidase activity was blocked by a 30-min preincubation in 0.1 M PBS, con-
taining 0.6% H2O2 and 0.12% sodium azide, and nonspecific binding sites were
blocked by incubation with 0.1 M PBS containing 0.5% bovine serum albumin
and 0.15% glycine for 10 min at RT. Subsequently, cells were incubated with
primary antibodies for 1 h at RT followed by a 45-min incubation with an
FIG. 1. Western blotting with specific antibodies to GFP of PC12
Tet-On (control) and stable transfected PC12/FMR7 cells with ()
and without () DOX induction. PC12/FMR7 cells show the presence
of a band of approximately 110 kDa after DOX induction with the
anti-GFP antibody, which is the expected size for the full-length
FMRP-GFP fusion protein (80 plus 27 kDa). In contrast, PC12/FMR7
cells without DOX induction are devoid of the 110-kDa band, repre-
senting the absence of nonspecific induction (leakage). In PC12
Tet-On cells no detection of the 110-kDa band was observed. Numbers
at left show molecular masses in kilodaltons.
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FIG. 2. Light microscopic appearance of movement of FMRP-GFP granules into neurites of PC12/FMR7 cells after DOX induction. The
FMRP-GFP fusion protein was visualized either directly by immunofluorescence of the GFP molecules (A to C) or by an indirect immunoper-
oxidase technique with specific antibodies to GFP (D to F). Without DOX induction (A and D; time zero) no reaction product could be visualized.
After 30 min of DOX induction FMRP-GFP fusion protein was present solely in the cell body (B and E). Exposure of the cells to DOX for 2 h
revealed a strong labeling in the cell body and a punctate labeling pattern in the neurites (C and F, arrows). Especially in the bright-field images
from the immunoperoxidase-incubated cells, swellings along the neurite with high concentrations of granules could be observed (F, arrows). Panels
G and H illustrate the endogenous FMRP expression in untransfected PC12 cells and primary mouse hippocampal neurons, respectively.
PC12/FMR7 cells were cultured for 30 min in the presence of DOX (I); subsequently cells were cultured for another 2 h in medium containing
DOX with (J) and without (K) the presence of cycloheximide. In the presence of cycloheximide the FMRP-GFP fusion protein is still able to reach
the neurites (K, arrows). Magnifications: A to C, 720; D to F, 960; G, 1,200; H, 960; I and K, 1,440; J, 800.
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HRP-conjugated secondary antibody. Enzymatic detection of antigen-antibody
complexes was achieved by incubation in substrate solution containing H2O2 and
3,3-diaminobenzidine tetrahydrochloride (DAB; DAKO). Finally, cells were
counterstained with hematoxylin and mounted with Aquamount (Gurr; BDH).
Labeling specificity was verified by incubations without primary or secondary
antibody. In both cases, background labeling was negligible.
Confocal microscopy. Time-lapse microscopy recording at physiological tem-
perature (37°C) of living stable transfected PC12 cells (PC12/FMR7) grown on
coverslips was performed in the presence of both NGF and DOX with a Zeiss
LSM510NLO microscope. The following setup was used: excitation, 488 nm;
0.5% acoustic optical tunable filter; main dichroic beam splitter (HFT); emission
filter, BP 500 to 550. Simultaneously with the fluorescent image a Nomarski
image was made.
For quantification, stable transfected cells were chosen by green fluorescence
and images were recorded and evaluated for the intensity of fluorescence at
different areas within the cell (cell body, neurite, and growth cone) with the Zeiss
advanced imaging microscopy software package. To calculate the average speed
(micrometers per second) of individual fluorescent granules, the distance trav-
eled from 25 different granules was measured during two or more consecutive
time-lapse frames (average number of frames, 12) with the Zeiss advanced
imaging microscopy software package and divided by time.
RESULTS
After DOX-induced expression, 11 stable transfected
Tet-On cell lines with pFMRP-EGFP were selected by screen-
ing for the presence of GFP by immunofluorescence micros-
copy. From those 11 cell lines we have chosen the PC12/FMR7
cell line by two criteria as the most suitable cell line for further
studies: first, FMRP-GFP expression levels after DOX induc-
tion were not too high, and second, without DOX FMRP-GFP
expression was absent. In particular, the moderate expression
level after DOX induction is important because high FMRP
expression levels have been shown previously to be toxic for
cells after transfection (10). Figure 1 shows a Western blot and
illustrates the presence of FMRP-GFP after DOX induction
and the absence of FMRP-GFP without DOX induction in the
PC12/FMR7 cell line. The observed molecular mass of approx-
imately 110 kDa is in line with what was expected, that is, 80
kDa for FMRP and 27 kDa for GFP. As a negative control, the
original PC12 Tet-On cell line that was used to generate the
stable transfectant cell line was included.
Further characterization of the PC12/FMR7 cell line was
performed to study the pattern of expression and cellular lo-
FIG. 3. (A) Figure corresponding to time-lapse series 1 (available
online); individual FMRP-GFP labeled granules were observed by
time-lapse microscopy. The time-lapse series shows the movement of
green fluorescent granules in PC12/FMR7 cells after DOX induction
(2 h) in a time-lapse study of frames every 5 s for 500 s. Note the
movement of fluorescent granules between the swelling along the
neurite (square 2) and the growth cone (rectangle 1). (B) Quantifica-
tion of the emission intensities over time (500 s). The overall emission
intensity in the cell body (square 3) remains the same over time,
whereas the emission intensity within the swelling (square 2) follows a
cycle every 3 min. The emission profile of the growth cone shows a
gradual increase of intensity during the recorded time (rectangle 1).
FIG. 4. Figure corresponding to time-lapse series 2 (available online); individual time-lapse frames were more highly integrated than those of
time-lapse series 1 (every second for 300 s). We have focused on the movement of granules between the swelling along the neurite and the growth
cone already described for time-lapse series 1. A selection of consecutive time-lapse frames illustrates the bidirectional movement (arrows) of an
individual granule. The bidirectional movement of this particular granule switched later in the time-lapse series to a distal unidirectional movement
followed by appearance in the growth cone.
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calization of FMRP-GFP after both NGF exposure and DOX
induction. In a time series experiment FMRP-GFP was visu-
alized either by direct visualization of green fluorescence (Fig.
2A to C) or by the indirect immunoperoxidase technique with
specific antibodies to GFP (Fig. 2D to F). At time zero (with
NGF exposure and without DOX induction) FMRP-GFP was
absent in PC12/FMR7 cells (Fig. 2A and D). At 30 min after
DOX induction FMRP-GFP was present in the cell body but
absent in the neurites (Fig. 2B and E). After 2 h of DOX
treatment, FMRP-GFP was present both in the cell body and
in the neurites, and especially in the neurites FMRP-GFP
appeared as granules (arrows, Fig. 2C and F).
As a control for the physiological relevance of the results
described above, the endogenous FMRP expression in both
PC12 cells (not transfected; Fig. 2G) and primary cultures of
mouse (wt) hippocampal neurons (Fig. 2H) was studied with
monoclonal antibodies to FMRP. Endogenous FMRP showed
a similar labeling pattern as that of FMRP-GFP in PC12/
FMR7 cells after DOX treatment.
From these steady-state images no conclusions could be
made as to whether the appearance of FMRP-GFP-positive
granules within the neurites was the result of transport from
the cell body or of local translation in the neurites. Therefore,
the expression pattern was studied again in a time series but
now in the presence of cycloheximide, an inhibitor of mRNA
translation. First PC12/FMR7 cells were exposed to NGF for
72 h followed by DOX induction for 30 min. Subsequently, the
DOX induction was continued for another 2 h but now in the
presence of cycloheximide. Figures 2I to K illustrate the results
of this experiment. After only 30 min of DOX induction,
FMRP-GFP was present solely in the cell body (Fig. 2I) as
shown above (Fig. 2E). Figures 2J and K show the presence of
FMRP-GFP in granules located in the neurites (arrows) in
cells after 2.5 h of DOX induction in the absence (Fig. 2J) and
presence (Fig. 2K) of cycloheximide. No differences in expres-
sion pattern could be observed between cells that were treated
with and without cycloheximide.
Time-lapse fluorescent microscopy. Time-lapse microscopy
was performed to study the cellular movement of FMRP-GFP-
positive granules in PC12/FMR7 cells, with special emphasis
on the trafficking into neurites. Figures 3 and 4 correspond to
time-lapse sequences 1 and 2, respectively (both time-lapse
versions are available online at www.eur.nl./fgg/ch1/pc12). The
first time-lapse sequence shows the movement of FMRP-GFP
granules in a time-lapse study of frames every 5 s for 500 s.
FMRP-GFP granules are continually moving out of the swell-
ing along the neurite (Fig. 3A, square 2) into distal neurites
(anterograde transport).
Quantification of the intensity of these fluorescent granules
and a graphic presentation are given in Fig. 3B for different
areas within the cell over time. The overall intensity in the cell
body remains the same during the total recorded time period
(Fig. 3B, square 3). In contrast, the intensity in the swelling
along the neurite varies over time, that is, approximately every
3 min we could observe a cycle in which the fluorescent inten-
sity slowly decreased and subsequently slowly increased. The
intensity in the growth cone (Fig. 3B, rectangle 1) gradually
increases over time. In this time-lapse microscopy experiment
we observed that the transport rate of the granules was too
high for accurate observation. Therefore, the movement of
FMRP-GFP granules was studied between the swelling along
the neurite and the growth cone within this same cell at shorter
time intervals (sequence 2, one frame per second for 300 s).
The movement of granules could be categorized as unidirec-
tional anterograde and oscillatory. Figure 4 shows a selection
of consecutive time-lapse frames (every 2 s) and illustrates the
bidirectional (anterograde and retrograde) movement of an
FMRP-GFP granule (Fig. 4, arrow). The movement of the
granules was not linear but rather saltatory, and not all gran-
ules were moving continuously. In addition, the average veloc-
ity of the FMRP-GFP particles has been determined by ana-
lyzing the motility characteristics of 25 different particles.
Thirty distances were measured, and an average speed of 0.19
 0.03 (standard error of the mean) m/s was calculated with
a maximum observed speed of 0.71 m/s.
Colocalization experiments and drug treatments. Colocal-
ization experiments were performed to further characterize
the FMRP-GFP granules by using specific antibodies to pro-
teins known to interact with FMRP and proteins already
known to be present in RNP particles. EtBr was used to label
total cellular RNA. PC12/FMR7 cells were exposed to NGF
for 72 h and subsequently treated for 24 h with both NGF and
DOX. Labeling with EtBr revealed an intense RNA signal in
the cell body and to a lesser extent in the neurites. In neurites,
EtBr staining overlaps with the FMRP-GFP granules (Fig. 5A
to C). We found a strong colocalization of FMRP-GFP gran-
ules and P0, a 60S ribosomal component (Fig. 5D to F). Stud-
ies of colocalization between FMRP-GFP and kinesin (heavy
chains), a microtubule-based motor molecule, demonstrated in
neurites an overlap between the two proteins (Fig. 5G to I).
Next, the codistribution of FMRP-GFP and FXR1P, a fragile
X-related protein and a known interactor with FMRP, was
studied, and again a clear colocalization could be observed
(Fig. 5J to L). The colocalization of FMRP-GFP with these
proteins and RNA was observed in both the bigger and smaller
granules. No colocalization with FMRP-GFP was observed
with nucleolin, MAP2, MAP1B, synaptophysin, neurofilament
(160 kDa), and dynein (C18, motor protein) (data not shown).
In neurons, both microtubules and/or microfilaments (e.g.,
actin) are involved in the transport of RNP particles into neu-
rites. Cytoskeleton-disrupting drugs were used to investigate
which transport system was responsible for movement of the
FMRP-GFP granules. These drugs were injected into the me-
dium after 30 min of treatment of the cells with DOX, to
FIG. 5. PC12/FMR7 cells (after 24 h of DOX treatment) double labeled on the one hand for FMRP-GFP (A, D, G, and J) and on the other
hand for total RNA (B), ribosomal subunits (P0) (E), kinesin heavy chain (H), and FXR1P (K). For each individual colocalization experiment we
have included an image that merges both separate images (green and red). Colocalization results in a yellow color (C, F, I, and L). Photographs
show part of a neurite and growth cone with two populations of granules (larger and smaller). Both types of granules show colocalization.
Magnifications: A to I, 2,880; J to L, 1,600.
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ensure that FMRP-GFP granules were not yet present in neu-
rites, for a total period of 2 h. Exposure of the cells to cytocha-
lasin D, which disrupts the actin filaments (12), had no effect
on the distribution of FMRP-GFP granules in the neurites.
Figures 6A to 6C illustrate the localization of F-actin (red) and
FMRP-GFP (green) without exposure to cytochalasin D.
Within the neurite a clear intact actin network could be ob-
served, especially in the growth cone, together with nonover-
lapping FMRP-GFP granules that had reached the growth
cone in the 2-h period. However, after exposure to cytochalasin
D (Fig. 6D to F) the actin network was destroyed (Fig. 6E), but
FMRP-GFP granules were normally localized within the neu-
rites (Fig. 6D, arrows). In contrast, treatment of PC12/FMR7
cells with nocodazole, which depolymerizes microtubules (41),
resulted in the absence of FMRP-GFP granules in the neurites.
Without nocodazole treatment, FMRP-GFP granules were
transported into the neurites (Fig. 6G, arrows) in the total
2.5-h time period of DOX induction, and the cells showed a
clear nonoverlapping microtubule network staining (Fig. 6H).
Interestingly, after nocodazole treatment FMRP-GFP gran-
ules were not transported into the neurites (Fig. 6J), which
showed only a very faint staining for microtubules (Fig. 6K,
arrows).
DISCUSSION
Localized mRNAs within mammalian cells provide the basis
for a spatial distribution of functions in a cell, and transloca-
tion of specific mRNAs to specific cellular compartments has
been reported for many cell types. A number of mRNAs have
been reported to be selectively targeted to dendrites of neu-
rons, and these include for instance mRNAs for MAP2, Arc,
CaMKII	, and glutamate receptors (7, 16, 22, 29). There is
evidence that for dendrites an active sorting mechanism is
involved. Certain neuronal mRNAs like MAP2 and CaMKII	
contain dendritic targeting signals in their 3 untranslated re-
gions (5, 30). Several potential mRNA binding proteins have
been identified which recognize these targeting sequences.
These proteins include hnRNP A2 and Staufen (18, 36). It has
been postulated that FMRP might perform a similar function
in transporting mRNAs containing a G-quartet structure and
in regulating their translation at the synapse (13). Therefore,
the distribution and transport of FMRP were studied in a
neuronal cell model system.
The neuroendocrine PC12 cell line originates from a rat
pheochromocytoma and is commonly used as a model system
for neuronal differentiation (17). Upon exposure to NGF,
PC12 cells develop neurites but no axons. Furthermore, differ-
entiated cells contain synapse-like vesicles, including synapse-
like vesicle membrane proteins (40). Here we describe the
development and characterization of an FMR1-EGFP stable
transfected PC12 cell line with a Tet-On expression system, for
tightly regulated expression of the FMR1-EGFP-encoding
gene in response to DOX induction. Using Western blotting,
we have shown that this cell line expresses a human full-length
FMRP-GFP fusion protein after DOX induction. Although
the Tet-On expression system is a high-level gene expression
system, we have chosen a cell line with only a moderate ex-
pression rate of FMRP-GFP compared to endogenous rat
Fmrp expression (data not shown). This enabled us to study
the FMRP distribution and transport dynamics in living PC12
cells at almost physiological expression levels in neuronal pro-
cesses during neuronal differentiation. Moreover, high FMRP
expression levels in transiently transfected cells have been
shown previously to have a toxic effect on the cells (10).
After DOX induction, FMRP-GFP appeared first in the cell
body and later as granules (RNP particles) moving into the
neurites. The size of the granules is not uniform, that is, two
different populations of granules exist, larger and smaller gran-
ules. The bigger granules are better represented in the distal
part of the neurites and growth cones. Ultimately, the granules
accumulate in the swellings along the neurite and in the growth
cone. Both time-lapse microscopy and steady-state localization
studies in the presence of cycloheximide, an inhibitor of
mRNA translation, demonstrate clearly the movement of
FMRP-GFP-positive granules into the neurites. Interestingly,
movement of the bigger granules was never observed; only the
smaller granules moved into the neurites. This phenomenon
and the fact that both types of granules showed colocalization
with RNA, FXR1P, kinesin, and P0 suggest that the smaller
ones fuse with each other to form the bigger ones.
Thus, at least part of the FMRP-GFP present in the growth
cone is due to transport out of the cell body into the neurites.
However, it is possible that local translation of FMR1-EGFP
mRNAs occurs simultaneously. In synaptoneurosome prepa-
rations from rat cortex, both Fmr1 mRNA and Fmrp could be
detected, and after mGluR1 stimulation a moderate increase
of Fmrp expression within translational complexes was ob-
served (42). These in vitro results suggest the occurrence of
local Fmr1 mRNA translation in dendrites.
Quantification of the FMRP-GFP fluorescent labeling sug-
gests a role for the swellings along the neurites as an interme-
diate in protein synthesis-transport between the cell body and
growth cones. Frequently the swellings along the neurite
branch off in several neurites. Perhaps the swellings along the
neurite represent an intermediate compartment bridging the
FIG. 6. Shown are fluorescent images of PC12/FMR7 cells after 30 min of DOX induction followed by further treatment in (i) control medium
(with DOX) for another 2 h (A, B, G, and H), (ii) medium supplemented with cytochalasin D for another 2 h (D and E), and (iii) medium
supplemented with nocodazole for another 2 h (J and K). Colocalization experiments were performed with phalloidin conjugated with Texas red
to visualize F-actin (B and E) and antibodies to tyrosine-tubulin to visualize microtubules (H and K). Treatment with cytochalasin D had no effect
on the localization of FMRP-GFP granules in the neurites (compare green fluorescence of panels A and D), while the F-actin labeling in the
neurites was completely abolished compared to that in untreated cells (compare red fluorescence of panels B and E). Treatment with nocodazole
abolished the microtubules (compare red fluorescence of panels H and K; arrows in panel K point to a neurite with only very faint staining for
tubulin), and FMRP-GFP granules were not transported into the neurites (compare green fluorescence of panels G and J, arrows). The two
individual images (red and green) of each experiment were merged (C, F, I, and L) to visualize colocalization (yellow). FMRP-GFP granules in
the neurites were not colocalized with either F-actin or tubulin. Magnifications: A to I, 2,400; J to L, 1,360.
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long distance between the cell body and the growth cone. Our
results show a decrease in intensity within the swelling every
1.5 min followed by a gradual increase of intensity in the
growth cone. Surprisingly, the decrease within the swelling is
succeeded by an increase within the same swelling during the
next 1.5 min. This cycle of deflation and expansion repeats
continuously over time. This increase may be due to either
transport of newly synthesized FMRP-GFP molecules out of
the cell body or local translation of FMR1 mRNAs. Whether
local FMR1 mRNA translation can occur within the swellings
along the neurite remains to be elucidated.
The FMRP-GFP-positive granules in the neurites displayed
two types of movement: oscillatory (bidirectional) over short
distances or unidirectional over larger distances in the direc-
tion of the growth cone (anterograde). The fact that only a
small proportion of the granules actually move within a neurite
has been reported elsewhere for SYTO14-, Staufen-GFP-, and
CaMKII	 3-untranslated region–GFP-labeled granules too
(23, 25, 32). The oscillatory movement of granules has been
attributed to fine local adjustments within specific dendritic
sites, i.e., clusters of synapses (32). We observed an average
velocity of 0.19 m/s, which is in line with earlier studies of
granular mRNA transport kinetics that have produced rates of
between 0.07 and 0.2 m/s (1, 24, 31).
The presence of RNA, ribosomal subunits, kinesin heavy
chain, and FXR1P in FMRP-GFP labeled granules further
illustrates the macromolecular structure of the granules. The
colocalization of FMRP-GFP labeled granules with RNA may
reflect the presence of individual mRNAs as well as rRNA
within the granules. Recent evidence suggests a role for these
mRNP particles in dendritic mRNA transport and suggests
that they may represent a mechanism in generating synaptic
plasticity (21). Each individual protein within the mRNP par-
ticle may have a specific function (cis- and trans-acting factors)
in recognition, transport, docking, stability, and translation
efficiency of mRNAs. Ribosomal subunits may represent com-
ponents of the translational machinery that are necessary at
the same site as the translocated mRNA (24). Kinesin mole-
cules are implied to play a role in mRNP particle transport
along microtubules, especially in large cell types like neurons
(4). Additionally, we demonstrate the microtubule-dependent
transport of FMRP-GFP labeled granules into neurites by us-
ing the microtubule-depolymerizing drug nocodazole. Disrup-
tion of the microtubules prevents the transport of FMRP-GFP
into neurites. In contrast, cytochalasin D, an actin-depolymer-
izing drug, has no influence on trafficking of the granules into
the neurites. In the present study we showed that in vivo
FMRP is also a component of the RNP particle. Thus, the
present evidence shows that FMRP-GFP is recruited in RNA-
containing granules representing RNP particles and trans-
ported into neurites along microtubules with an average speed
of approximately 0.2 m/s.
Synaptic plasticity may require local synthesis of proteins at
the postsynaptic sites in response to synaptic activity. The local
protein synthesis involves mRNAs already in place or traffick-
ing of specific mRNAs induced by synaptic activity from the
cell body into dendrites. Only a small subset of the total pool
of mRNAs is transported into dendrites; thus, differential in-
tracellular sorting of specific mRNAs is necessary to maintain
the asymmetric distribution of mRNAs. The function of FMRP
within the mRNP particle might represent a role in this selec-
tive targeting of specific mRNAs. FMRP is an RNA binding
protein that binds with high affinity to mRNAs via a G quartet
(13, 33). Several mRNAs that contain a G quartet with a high
affinity for FMRP were identified, and some were underrep-
resented in polysomes of lymphoblast cells from fragile X
patients, including MAP1B and semaphorin (6). Only a minor-
ity (4%) of the total mRNA pool contains such a G quartet;
thus, the presence of a G quartet serves as a zip code for
selective targeting of those mRNAs to dendrites. The cognitive
deficits in fragile X syndrome are caused by the absence of
FMRP in neurons and might be induced by misrouting and/or
misregulation of specific G-quartet-containing mRNAs into
dendrites, mRNAs which encode important neuronal proteins,
including MAP1B and semaphorin. The new PC12 model sys-
tem described in the present report might serve as an impor-
tant tool to isolate and characterize the in vivo target mRNAs
of FMRP in continuing studies using combined laser-dissection
microscopy with reverse transcription-PCR and in situ hybrid-
ization techniques. Further identification of mRNA targets of
FMRP, especially those mRNAs involved in normal synaptic
activity, might provide knowledge about the role of FMRP in
synaptic plasticity and memory storage.
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